Onconetix, Inc. (ONCO)
0.4788
-0.07
(-12.63%)
USD |
NASDAQ |
Oct 16, 16:00
0.5301
+0.05
(+10.71%)
After-Hours: 20:00
Onconetix Market Cap : 1.816M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.816M |
| October 15, 2026 | 2.079M |
| October 14, 2026 | 2.079M |
| October 13, 2026 | 2.106M |
| October 12, 2026 | 2.240M |
| October 09, 2026 | 2.352M |
| October 08, 2026 | 2.482M |
| October 07, 2026 | 2.266M |
| October 06, 2026 | 2.508M |
| October 05, 2026 | 2.553M |
| October 02, 2026 | 2.783M |
| October 01, 2026 | 2.823M |
| September 30, 2026 | 2.968M |
| September 29, 2026 | 3.111M |
| September 28, 2026 | 4.211M |
| September 25, 2026 | 3.908M |
| September 24, 2026 | 3.456M |
| September 23, 2026 | 3.452M |
| September 22, 2026 | 2.592M |
| September 21, 2026 | 2.484M |
| September 18, 2026 | 2.424M |
| September 17, 2026 | 2.517M |
| September 16, 2026 | 2.517M |
| September 15, 2026 | 2.448M |
| September 14, 2026 | 2.418M |
| Date | Value |
|---|---|
| September 11, 2026 | 2.870M |
| September 10, 2026 | 2.967M |
| September 09, 2026 | 3.085M |
| September 08, 2026 | 3.187M |
| September 04, 2026 | 3.870M |
| September 03, 2026 | 2.804M |
| September 02, 2026 | 2.558M |
| September 01, 2026 | 2.476M |
| August 31, 2026 | 2.378M |
| August 28, 2026 | 2.323M |
| August 27, 2026 | 2.398M |
| August 26, 2026 | 2.432M |
| August 25, 2026 | 2.439M |
| August 24, 2026 | 2.489M |
| August 21, 2026 | 2.468M |
| August 20, 2026 | 2.530M |
| August 19, 2026 | 2.697M |
| August 18, 2026 | 2.846M |
| August 17, 2026 | 2.874M |
| August 14, 2026 | 3.078M |
| August 13, 2026 | 3.348M |
| August 12, 2026 | 3.382M |
| August 11, 2026 | 3.673M |
| August 10, 2026 | 0.2473M |
| August 07, 2026 | 0.2456M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vistagen Therapeutics, Inc. | 8.876M |
| BridgeBio Pharma, Inc. | 12.96B |
| ACADIA Pharmaceuticals, Inc. | 3.291B |
| Alnylam Pharmaceuticals, Inc. | 31.00B |
| Anika Therapeutics, Inc. | 267.39M |
Market Cap Related Metrics
| PS Ratio | 0.4384 |
| Price to Book Value | 0.1349 |
| Price | 0.4788 |
| Earnings Yield | -41.58K% |